L-Ornithine L-Aspartate Injection

What is L-Ornithine L-Aspartate Injection?
L-Ornithine L-Aspartate (LOLA) Injection is a hepatoprotective and ammonia-lowering agent used to support liver function in patients with elevated blood ammonia levels. It is widely used in hepatic encephalopathy, cirrhosis, and acute or chronic liver disease. The injection provides rapid detoxification by enhancing the urea cycle and glutamine synthesis.
 
Uses of L-Ornithine L-Aspartate Injection
• Treatment of hepatic encephalopathy
• Management of hyperammonemia
• Supportive therapy in liver cirrhosis
• Acute and chronic liver disease
• Detoxification and improvement of liver metabolism
 
How Does L-Ornithine L-Aspartate Injection Work?
LOLA works by enhancing urea cycle activity and stimulating glutamine synthesis, both of which help convert toxic ammonia into harmless substances that can be safely eliminated. This reduces ammonia levels in the blood, improves mental clarity, and supports overall liver function.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of L-Ornithine L-Aspartate (LOLA) Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of L-Ornithine L-Aspartate Injection. We produce high-quality sterile hepatoprotective injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for liver support and critical care.
Q: What strengths and packaging options does Farbe Firma offer for LOLA Injection?
A: We manufacture L-Ornithine L-Aspartate Injection primarily in the strength of 500 mg/mL. Our standard packaging is a 10 mL ampoule. We also offer customizable packaging solutions and concentrations to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for LOLA Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Liver Support Injectables?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for L-Ornithine L-Aspartate Injection. Pharmaceutical companies looking for a reliable partner for sterile nutritional and metabolic products can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication of the L-Ornithine L-Aspartate produced by Farbe Firma?
A: Our LOLA Injection is indicated for the treatment of hyperammonemia (elevated blood ammonia levels) secondary to acute or chronic liver disease, particularly for the management of hepatic encephalopathy (HE). It works by enhancing the liver's detoxification process.
 
Looking for a reliable L-Ornithine L-Aspartate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for dossier support, regulatory documentation, and global export supplies.